To validate if BUB1B and circBUB1B_544aa were promising MM therapeutic targets, three siRNA pieces were designed to target the kinase catalytic center sequence of both the circBUB1B_544aa and its linear counterpart (Fig. 7a). The gene discussed is BUB1B; the disease is Miyoshi myopathy.